Johnson & Johnson to Acquire Synthes for US$21.3 B in Cash and Stock
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 5 (Table of Contents)
Published: 9 May-2011
DOI: 10.3833/pdr.v2011.i5.1469 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In what is by far its largest acquisition to date, Johnson & Johnson (J&J) has entered into a definitive agreement to buy the trauma device maker Synthes for approximately US$21...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS